TBX10抗体

+ +

•  

   

     Microtiter wells were coated with human immunoglobulins with various isotypes. P15001 was used as the primary antibody and peroxidase conjugated goat anti-mouse IgG was used as the secondary antibody. Result: P15001 does not cross-react with human IgG1, IgG2, IgG3, IgG4, IgM and IgE.    

  
  

•  

   

     Lane 1: 100 ng of human IgA;  Lane 2: 100 ng of human IgM;  Lane 3: 100 ng of human IgG;Lane 4: 100 ng of human IgE;  Result: P15001 can specifically detect human IgA by Western blotting.    

  
  

•  

   

     IHC-P analysis of tonsil tissue by IgA antibody (P15001) IHC-P was performed using sections of the formalin-fixed paraffin-embedded tonsil tissue;Result: Germinal center cells and squamous epithelial cells are positively stained at the cytoplasm.    

  
  

The TBX10 antibody is a research tool targeting the T-box transcription factor 10 (TBX10), a member of the evolutionarily conserved T-box gene family. These proteins play critical roles in embryonic development, tissue differentiation, and organogenesis by regulating gene expression through DNA-binding T-domain motifs. TBX10. specifically, is implicated in developmental processes such as limb formation, heart morphogenesis, and nervous system patterning. While less studied than related family members (e.g., TBX5 in Holt-Oram syndrome), TBX10 has been linked to regulating progenitor cell differentiation and tissue-specific gene networks in model organisms.

Antibodies against TBX10 enable detection and localization of the protein in cells and tissues, supporting applications like immunohistochemistry, Western blotting, and immunofluorescence. They are vital for studying TBX10's expression dynamics during embryogenesis, its interaction partners, and its role in congenital anomalies or diseases. Research suggests TBX10 dysfunction may contribute to developmental disorders, though its exact pathological mechanisms remain under investigation. Commercial TBX10 antibodies are typically validated for specificity using knockout controls or siRNA-mediated protein suppression.

Current studies focus on TBX10's regulatory crosstalk with signaling pathways (e.g., Wnt, BMP) and its potential involvement in cancer or regenerative processes, highlighting its broader biomedical relevance.